HSD11B2 activity, as measured by the serum F/E ratio, was significantly higher in patients with CKD than controls, indicative of reduced HSD11B2 activity in CKD (serum F/E ratio 10.9 vs 5.4, P < .0001). Here, HSD11B2 is linked to chronic kidney disease.